JP2010540422A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540422A5 JP2010540422A5 JP2010525422A JP2010525422A JP2010540422A5 JP 2010540422 A5 JP2010540422 A5 JP 2010540422A5 JP 2010525422 A JP2010525422 A JP 2010525422A JP 2010525422 A JP2010525422 A JP 2010525422A JP 2010540422 A5 JP2010540422 A5 JP 2010540422A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound according
- alkyl
- hydrogen
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 12
- 239000001257 hydrogen Substances 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 6
- -1 benzimidazol-2-yl-methyl Chemical group 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000002950 monocyclic group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 150000002829 nitrogen Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 1
- 208000006673 Asthma Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0718434A GB0718434D0 (en) | 2007-09-21 | 2007-09-21 | New chemical compounds |
| PCT/GB2008/003173 WO2009037463A1 (en) | 2007-09-21 | 2008-09-19 | Thienopyrimidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540422A JP2010540422A (ja) | 2010-12-24 |
| JP2010540422A5 true JP2010540422A5 (de) | 2011-11-04 |
Family
ID=38670289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525422A Pending JP2010540422A (ja) | 2007-09-21 | 2008-09-19 | チエノピリミジン化合物類 |
Country Status (5)
| Country | Link |
|---|---|
| US (5) | US9120807B2 (de) |
| EP (1) | EP2205607A1 (de) |
| JP (1) | JP2010540422A (de) |
| GB (1) | GB0718434D0 (de) |
| WO (1) | WO2009037463A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2567959B1 (de) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren |
| US10793636B2 (en) | 2016-07-11 | 2020-10-06 | Corvus Pharmaceuticals, Inc. | Anti-CD73 antibodies |
| CA3073915A1 (en) | 2017-08-31 | 2019-03-07 | Corvus Pharmaceuticals, Inc. | Compounds and methods for modulating adenosine a2b receptor and adenosine a2a receptor |
| WO2023201267A1 (en) | 2022-04-13 | 2023-10-19 | Gilead Sciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117878A (en) | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
| GB9915437D0 (en) * | 1999-07-01 | 1999-09-01 | Cerebrus Ltd | Chemical compounds III |
| EP1467995B1 (de) * | 2001-12-20 | 2010-05-19 | OSI Pharmaceuticals, Inc. | Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung |
| NZ528591A (en) | 2002-02-01 | 2006-11-30 | King Pharmaceuticals Res & Dev | 8-heteroaryl xanthine adenosine A2B receptor antagonists and their pharmaceutical use |
| KR20060111467A (ko) * | 2003-10-31 | 2006-10-27 | 씨브이 쎄러퓨틱스, 인코포레이티드 | Ａ2ｂ 아데노신 수용체 안타고니스트 |
| EP1989210A2 (de) * | 2006-03-02 | 2008-11-12 | Cv Therapeutics, Inc. | A2a-adenosinrezeptorantagonisten |
-
2007
- 2007-09-21 GB GB0718434A patent/GB0718434D0/en not_active Ceased
-
2008
- 2008-09-19 WO PCT/GB2008/003173 patent/WO2009037463A1/en active Application Filing
- 2008-09-19 US US12/678,378 patent/US9120807B2/en active Active
- 2008-09-19 JP JP2010525422A patent/JP2010540422A/ja active Pending
- 2008-09-19 EP EP20080806328 patent/EP2205607A1/de not_active Withdrawn
-
2015
- 2015-07-20 US US14/803,214 patent/US9610290B2/en active Active
-
2017
- 2017-02-20 US US15/436,988 patent/US9920066B2/en active Active
-
2018
- 2018-02-08 US US15/891,618 patent/US10556911B2/en active Active
-
2019
- 2019-12-24 US US16/726,308 patent/US11028097B2/en active Active